As the second leading infectious killer after COVID-19, tuberculosis (TB) is considered a major worldwide health threat – accounting for nearly two million deaths annually, according to the... read more
As the second leading infectious killer after COVID-19, tuberculosis (TB) is considered a major worldwide health threat – accounting for nearly two million deaths annually, according to the... read more
Novartis has signed a deal with the Medicines Patent Pool to allow generic production of its patented drug Tasigna (nilotinib) to treat chronic myeloid leukemia (CML). This landmark agreement... read more
AVEO Oncology has agreed to an acquisition by Korean firm LG Chem for $566M in an all-cash deal. The offering price of $15.00/share represents a 43% premium over AVEO's closing price on Monday,... read more
... read more
Two global innovators join to support overburdened doctors and isolated patients with award-winning patient-first digital-first technology